Cost-effective reimbursement analysis for medical technologies in Europe
Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries
White Paper: Evidence requirements for medical devices in the regional HTA program in Italy
Get insights from MTRC White Papers to advance your understanding of five rapid HTA reports from the Tuscany region
Recent news and posts
Technologies prioritized for evaluation within the National HTA Program in 2025 in Italy
The National HTA Program (Programma Nazionale di Health Technology Assessment, PNHTA) became fully operational in 2023, when the Ministry of Health published the Decree on the adoption of PNHTA 2023-2025.
PNHTA 2023-2025 is focused on medical devices. It is led by a national Steering Committee for the health technology assessment of medical devices (Cabina di Regia HTA DM) created by the Ministry of Health, and coordinated by the National Agency for Regional Health Services (AGENAS). The program aims to develop national HTAs and integrate their recommendations into decision-making on reimbursement and procurement within the national healthcare system at all levels (national, regional, and healthcare provider).
On October 14, 2025, the AGENAS published the list of technologies identified by the Steering Committee as priorities for evaluation within the National HTA Program for medical devices in 2025.
The following technologies have been prioritized, and HTAs are currently in progress:
- Continuous glucose monitoring (CGM) devices for patients with diabetes;
- Treatments for benign prostatic hyperplasia;
- Optune Gio system for tumor treating fields (TTF) therapy in glioblastoma;
- GammaPod system for stereotactic breast radiotherapy.
See more details in Italian here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.